MSRA-1379
A 35-year-old woman presents with lethargy, arthralgia and a facial rash and is diagnosed with systemic lupus erythematosus. Her rheumatologist initiates treatment with hydroxychloroquine. What is the most crucial parameter to monitor during her treatment?